Details for New Drug Application (NDA): 203923
✉ Email this page to a colleague
The generic ingredient in SODIUM THIOSULFATE is sodium thiosulfate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the sodium thiosulfate profile page.
Summary for 203923
Tradename: | SODIUM THIOSULFATE |
Applicant: | Hope Pharms |
Ingredient: | sodium thiosulfate |
Patents: | 5 |
Suppliers and Packaging for NDA: 203923
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SODIUM THIOSULFATE | sodium thiosulfate | SOLUTION;INTRAVENOUS | 203923 | NDA | Hope Pharmaceuticals | 60267-705 | 60267-705-50 | 50 mL in 1 VIAL, SINGLE-DOSE (60267-705-50) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 12.5GM/50ML (250MG/ML) | ||||
Approval Date: | Feb 14, 2012 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Jul 7, 2030 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | SODIUM THIOSULFATE INJECTION IS ADMINISTERED BY INTRAVENOUS INJECTION | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Feb 10, 2030 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
Patented Use: | SODIUM THIOSULFATE INJECTION IS INDICATED FOR SEQUENTIAL USE WITH SODIUM NITRITE FOR THE TREATMENT OF ACUTE CYANIDE POISONING THAT IS JUDGED TO BE SERIOUS OR LIFE-THREATENING | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Mar 29, 2031 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
Patented Use: | TREATMENT OF ACUTE CYANIDE POISONING THAT IS JUDGED TO BE LIFE THREATENING |
Complete Access Available with Subscription